Effectiveness of Hypertension Treatments in Patients of African Caribbean and South Asian Descent
Hypertension, or high blood pressure, is a leading cause of cardiovascular disease and death worldwide, as reported by the World Health Organization. It is observed that certain ethnic groups are more prone to developing hypertension at an earlier age. Studies have shown that individuals of African, Caribbean, and South Asian ancestry are diagnosed with hypertension at higher rates compared to other populations.
Among these groups, individuals with Caribbean heritage are found to have a higher prevalence of hypertension when compared to black West African or Caucasian individuals. Surprisingly, South Asian people, despite having lower cholesterol levels than Caucasians, experience more severe atherosclerosis and ischaemic-end organ damage as a result of hypertension.
When it comes to pharmacological treatments for hypertension, researchers have found that African Caribbean patients tend to respond better to calcium channel blockers (CCBs) and diuretics compared to other types of antihypertensive medications like ACE inhibitors. However, studies suggest that South Asian individuals may not derive the same benefits from CCBs.
Further research is underway to determine the effectiveness of specific antihypertensive agents for individuals of different ethnic backgrounds. Understanding these variations can help healthcare professionals tailor their treatment approaches to better suit the needs of patients from African Caribbean and South Asian descent.
CCBs and Older Patients
Managing hypertension becomes increasingly challenging as individuals age due to changes in their physiology. Among patients aged 65 and older, high blood pressure is not only more common but also more difficult to control. Research indicates that calcium channel blockers (CCBs) are particularly effective in preventing strokes in older patients, largely due to their ability to lower blood pressure without significant side effects. While diuretics may be a more cost-effective option, healthcare professionals have expressed concerns that even moderate doses of these medications could potentially contribute to the development of type 2 diabetes, insulin resistance, and hyperkalemia in older patients.